文献速递产科母胎医学

瑞典普遍与非普遍检测下SARS-CoV-2感染与妊娠结局的全国性队列研究

SARS-CoV-2 and pregnancy outcomes under universal and non-universal testing in Sweden: register-based nationwide cohort study.
PubMed 文献 · BJOG · 2021-11-18

研究发现检测策略和阳性至分娩间隔影响关联强度:普遍检测下阳性至分娩≤10天者新生儿监护入住率升高(15.3% vs 8.0%;aOR 2.24,95%CI 1.62-3.11),但5分钟Apgar评分<7和死产无显著关联;医学指征早产风险升高(5.7% vs 2.1%;aOR 2.70,95%CI 1.60-4.58),自发性早产无显著增加。

要点

  • 检测策略影响SARS-CoV-2与不良妊娠结局的关联估计,非普遍检测可能高估关联。
  • 普遍检测下,阳性至分娩≤10天者新生儿监护入住风险升高(aOR 2.24)。
  • SARS-CoV-2阳性与医学指征早产风险升高相关(aOR 2.70)。

核心结论

  • 检测策略和阳性至分娩间隔影响SARS-CoV-2阳性与妊娠结局的关联,非普遍检测下近分娩并发症者更易检测从而夸大关联。

主要发现

  • 普遍检测下,阳性至分娩≤10天者新生儿监护入住率15.3% vs 8.0%(aOR 2.24,95%CI 1.62-3.11)。
  • 5分钟Apgar评分<7(1.0% vs 1.7%;aOR 0.64,95%CI 0.24-1.72)和死产(0.3% vs 0.4%;aOR 0.72,95%CI 0.10-5.20)无显著关联。
  • 医学指征早产中阳性率5.7% vs 足月产2.1%(aOR 2.70,95%CI 1.60-4.58),自发性早产2.3%(aOR 1.12,95%CI 0.62-2.02)无显著增加。
  • 阳性至分娩>10天者,两种检测策略下风险一般无显著差异。

关键数值与推荐

  • 阳性至分娩≤10天者新生儿监护入住aOR 2.24(95%CI 1.62-3.11)。
  • 医学指征早产aOR 2.70(95%CI 1.60-4.58),自发性早产aOR 1.12(95%CI 0.62-2.02)。

临床怎么用

  • 解读SARS-CoV-2与妊娠结局关联时需考虑检测策略和阳性至分娩间隔,避免非普遍检测下的选择偏倚夸大风险。
  • 对近分娩期SARS-CoV-2阳性孕妇,应关注新生儿监护入住风险。
  • SARS-CoV-2阳性可能与医学指征早产相关,需加强相应产科管理。

局限性

  • 观察性设计可能残留混杂。
  • 检测策略非随机,组间可比性受限。
  • 阳性至分娩间隔依赖登记数据准确性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess associations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and pregnancy outcomes considering testing policy and test-positivity-to-delivery interval. DESIGN: Nationwide cohort study. SETTING: Sweden. POPULATION: From the Pregnancy-Register we identified 88 593 singleton births, 11 March 2020-31 January 2021, linked to data on SARS-CoV-2-positivity from the Public Health Agency, and information on neonatal care admission from the Neonatal Quality Register. Adjusted odds ratios (aORs) were estimated stratified by testing-policy and test-positivity-to-delivery interval. MAIN OUTCOME MEASURES: Five-minute Apgar score, neonatal care admission, stillbirth and preterm birth. RESULTS: During pregnancy, SARS-CoV-2 test-positivity was 5.4% (794/14 665) under universal testing and 1.9% (1402/73 928) under non-universal testing. There were generally lower risks associated with SARS-CoV-2 under universal than non-universal testing. In women testing positive >10 days from delivery, generally no significant differences in risk were observed under either testing policy. Neonatal care admission was more common (15.3% versus 8.0%; aOR 2.24, 95% CI 1.62-3.11) in women testing positive ≤10 days before delivery under universal testing. There was no significant association with 5-minute Apgar score below 7 (1.0% versus 1.7%; aOR 0.64, 95% CI 0.24-1.72) or stillbirth (0.3% versus 0.4%; aOR 0.72, 95% CI 0.10-5.20). Compared with term births (2.1%), test-positivity was higher in medically indicated preterm birth (5.7%; aOR 2.70, 95% CI 1.60-4.58) but not significantly increased in spontaneous preterm birth (2.3%; aOR 1.12, 95% CI 0.62-2.02). CONCLUSIONS: Testing policy and timing of test-positivity impact associations between SARS-CoV-2-positivity and pregnancy outcomes. Under non-universal testing, women with complications near delivery are more likely to be tested than women without complications, thereby inflating any association with adverse pregnancy outcomes compared with findings under universal testing. TWEETABLE ABSTRACT: Testing policy and time from SARS-CoV-2 infection to delivery influence the association with pregnancy outcomes.

来源:BJOG,查看原文。版权归原作者所有。

引用

  1. Stephansson O, Pasternak B, Ahlberg M, et al. SARS-CoV-2 and pregnancy outcomes under universal and non-universal testing in Sweden: register-based nationwide cohort study. BJOG. 2021. PMID: 34706148. doi:10.1111/1471-0528.16990

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。